This presentation was given jointly with Shahram Moradpour, Sun Microsystems, United States
- Counterfeit pharmaceuticals and biologics are a growing problem affecting patient safety
- RFID minimizes the risk of counterfeited and diverted product by allowing companies to track each drug as it moves through the supply chain
- RFID coupled with Electronic Product Code (EPC) and electronic pedigrees are key elements recommended by the FDA to combat counterfeit drugs
- Companies can gain business value in expedited returns processing and more precise recalls in addition to operational efficiencies
Presentation*
Audio*
Forward Page
